Higher risk for COVID-19-related hospitalization, death in HIV-positive individuals

Key clinical point: HIV-positive individuals are more likely to be hospitalized for or die from COVID-19 compared with non-HIV individuals.

Major finding: The HIV-positive vs non-HIV group had a higher risk for COVID-19-related hospitalization (adjusted odds ratio [aOR], 1.20; 95% CI, 1.15-1.26) and mortality (aOR, 1.29; 95% CI, 1.16-1.44). The risk was pronounced for older patients, male sex, and Black race.

Study details: The data come from a US population-based surveillance study involving 1,436,622 COVID-19 cases, of which 13,170 were HIV positive.

Disclosures: The study was funded by National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases, and National Institutes of Health, USA. The authors declared no competing interests.

Source: Yang X et al. Lancet HIV. 2021 Oct 13. doi: 10.1016/S2352-3018(21)00239-3.

Key clinical point: HIV-positive individuals are more likely to be hospitalized for or die from COVID-19 compared with non-HIV individuals.

Major finding: The HIV-positive vs non-HIV group had a higher risk for COVID-19-related hospitalization (adjusted odds ratio [aOR], 1.20; 95% CI, 1.15-1.26) and mortality (aOR, 1.29; 95% CI, 1.16-1.44). The risk was pronounced for older patients, male sex, and Black race.

Study details: The data come from a US population-based surveillance study involving 1,436,622 COVID-19 cases, of which 13,170 were HIV positive.

Disclosures: The study was funded by National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases, and National Institutes of Health, USA. The authors declared no competing interests.

Source: Yang X et al. Lancet HIV. 2021 Oct 13. doi: 10.1016/S2352-3018(21)00239-3.

Key clinical point: HIV-positive individuals are more likely to be hospitalized for or die from COVID-19 compared with non-HIV individuals.

Major finding: The HIV-positive vs non-HIV group had a higher risk for COVID-19-related hospitalization (adjusted odds ratio [aOR], 1.20; 95% CI, 1.15-1.26) and mortality (aOR, 1.29; 95% CI, 1.16-1.44). The risk was pronounced for older patients, male sex, and Black race.

Study details: The data come from a US population-based surveillance study involving 1,436,622 COVID-19 cases, of which 13,170 were HIV positive.

Disclosures: The study was funded by National Center for Advancing Translational Sciences, National Institute of Allergy and Infectious Diseases, and National Institutes of Health, USA. The authors declared no competing interests.

Source: Yang X et al. Lancet HIV. 2021 Oct 13. doi: 10.1016/S2352-3018(21)00239-3.